Barclays’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-69,500
| Closed | -$4.69M | – | 5417 |
|
|
2025
Q3 | $4.69M | Buy |
+69,500
| New | +$4.61M | ﹤0.01% | 2254 |
|
|
2024
Q1 | – | Sell |
-31,100
| Closed | -$2.22M | – | 5203 |
|
|
2023
Q4 | $2.22M | Buy |
+31,100
| New | +$2.17M | ﹤0.01% | 2828 |
|
|
2020
Q3 | – | Sell |
-1,100
| Closed | -$63K | – | 5350 |
|
|
2020
Q2 | $63K | Sell |
1,100
-5,800
| -84% | -$285K | ﹤0.01% | 4817 |
|
|
2020
Q1 | $242K | Buy |
6,900
+5,900
| +590% | +$281K | ﹤0.01% | 4136 |
|
|
2019
Q4 | $52K | Sell |
1,000
-1,900
| -66% | -$94.6K | ﹤0.01% | 5728 |
|
|
2019
Q3 | $146K | Buy |
2,900
+2,100
| +263% | +$103K | ﹤0.01% | 5187 |
|
|
2019
Q2 | $38K | Buy |
800
+300
| +60% | +$13.9K | ﹤0.01% | 6210 |
|
|
2019
Q1 | $24K | Sell |
500
-1,700
| -77% | -$76.7K | ﹤0.01% | 6281 |
|
|
2018
Q4 | $90K | Sell |
2,200
-21,900
| -91% | -$898K | ﹤0.01% | 5111 |
|
|
2018
Q3 | $987K | Sell |
24,100
-25,100
| -51% | -$1.01M | ﹤0.01% | 3629 |
|
|
2018
Q2 | $1.96M | Buy |
49,200
+39,700
| +418% | +$1.53M | ﹤0.01% | 2607 |
|
|
2018
Q1 | $355K | Sell |
9,500
-20,000
| -68% | -$808K | ﹤0.01% | 4301 |
|
|
2017
Q4 | $1.26M | Buy |
29,500
+25,600
| +656% | +$1.02M | ﹤0.01% | 2875 |
|
|
2017
Q3 | $143K | Sell |
3,900
-7,300
| -65% | -$295K | ﹤0.01% | 4675 |
|
|
2017
Q2 | $508K | Buy |
11,200
+5,200
| +87% | +$230K | ﹤0.01% | 3512 |
|
|
2017
Q1 | $255K | Sell |
6,000
-22,400
| -79% | -$913K | ﹤0.01% | 4066 |
|
|
2016
Q4 | $1.14M | Buy |
28,400
+21,700
| +324% | +$837K | ﹤0.01% | 2627 |
|
|
2016
Q3 | $260K | Sell |
6,700
-6,500
| -49% | -$245K | ﹤0.01% | 3738 |
|
|
2016
Q2 | $457K | Buy |
13,200
+10,000
| +313% | +$346K | ﹤0.01% | 3287 |
|
|
2016
Q1 | $109K | Sell |
3,200
-10,900
| -77% | -$380K | ﹤0.01% | 4288 |
|
|
2015
Q4 | $536K | Sell |
14,100
-47,200
| -77% | -$1.84M | ﹤0.01% | 3159 |
|
|
2015
Q3 | $2.39M | Buy |
61,300
+26,700
| +77% | +$1.06M | ﹤0.01% | 1967 |
|
|
2015
Q2 | $1.31M | Sell |
34,600
-39,700
| -53% | -$1.39M | ﹤0.01% | 2630 |
|
|
2015
Q1 | $2.45M | Buy |
74,300
+45,500
| +158% | +$1.4M | ﹤0.01% | 2121 |
|
|
2014
Q4 | $749K | Buy |
28,800
+23,600
| +454% | +$609K | ﹤0.01% | 3462 |
|
|
2014
Q3 | $125K | Sell |
5,200
-6,600
| -56% | -$167K | ﹤0.01% | 5146 |
|
|
2014
Q2 | $295K | Sell |
11,800
-61,500
| -84% | -$1.44M | ﹤0.01% | 4450 |
|
|
2014
Q1 | $1.54M | Buy |
73,300
+66,700
| +1,011% | +$1.44M | ﹤0.01% | 2813 |
|
|
2013
Q4 | $145K | Sell |
6,600
-31,300
| -83% | -$690K | ﹤0.01% | 5312 |
|
|
2013
Q3 | $758K | Sell |
37,900
-7,900
| -17% | -$168K | ﹤0.01% | 3658 |
|
|
2013
Q2 | $884K | Buy |
+45,800
| New | +$957K | ﹤0.01% | 3546 |
|
Other funds holding HOLX
VCM
HI
VPM
Barclays's HOLX Position: Q1 2026 in Review
Barclays increased its Hologic (HOLX) stake by 59% in Q1 2026, buying an estimated $20.8M and bringing the position to 746,127 shares worth $56.4M. The position accounts for 0.01% of the portfolio, ranked #684.
Barclays first reported a position in HOLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $58.5M in Q3 2024. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.
- Barclays held 746,127 shares of Hologic worth $56.4M as of Q1 2026.
- Barclays bought 277,107 Hologic shares in Q1 2026, an estimated $20.8M.
- Hologic made up 0.01% of Barclays's portfolio in Q1 2026, its #684 holding.
- Barclays first reported a position in Hologic in Q2 2013 and has held it in 52 quarters since.
- Barclays's Hologic position peaked at $58.5M in Q3 2024.
- 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.